Rishabh Chalotra | Metabolic Disorders | Young Researcher Award

Published-on by Indian Scientist

Mr. Rishabh Chalotra | Metabolic Disorders | Young Researcher Award

Central University of Punjab | India

Rishabh Chalotra is a CSIR-Senior Research Fellow and doctoral scholar at the Laboratory of Neuroendocrinology and Metabolic Disorders, Department of Pharmacology, Central University of Punjab. His research focuses on addressing the complexities of Metabolic Syndrome through preclinical studies, exploring the therapeutic potential of natural phytoconstituents, and developing herbal-based solutions for improved clinical outcomes. He holds a Master’s degree in Pharmacology and a Bachelor’s degree in Pharmacy, with extensive experience in animal models, biochemical assays, pharmacokinetic studies, ELISA, RT-PCR, flow cytometry, and other advanced laboratory techniques. Rishabh has contributed to 18 peer-reviewed articles, six book chapters, and four patents, with his work cited 127 times, reflecting an h-index of 6 and an i10-index of 5. His publications explore metabolic disorders, diabetic complications, neurodegenerative diseases, and drug discovery, highlighting the role of flavonoids and natural compounds in therapeutic interventions. He has received the Young Investigator Award from the Indian Pharmacological Society and is a lifetime member of professional societies including the Indian Pharmacological Society, American Society for Microbiology, and British Pharmacological Society. His research combines experimental pharmacology with translational applications to bridge knowledge gaps and improve patient outcomes, positioning him as a promising contributor to global pharmacological research.

Profile: Google Scholar

Featured Publication

Chauhan, S., Chalotra, R., Rathi, A., Saini, M., Deol, S., Lard, M., & Gupta, S. (2023). Current approaches in healing of wounds in diabetes and diabetic foot ulcers. Current Bioactive Compounds, 19(3), 104–121.

Chalotra, R., Gupta, T., Chib, S., Amanat, M., Kumar, P., & Singh, R. (2024). Treatment of diabetic complications: Do flavonoids hold the keys? Critical Reviews in Food Science and Nutrition, 64(30), 11091–11112.

Maqbool, M., Chaudhary, K., Chalotra, R., Chauhan, S., & Dahiya, R. S. (2024). Phyto-pharmacology of most common Indian culinary spices and their potential in developing new pharmaceutical therapies. Current Traditional Medicine, 10(2), 117–140.

Sharma, K., Chib, S., Gupta, A., Singh, R., & Chalotra, R. (2024). Interplay between α-synuclein and parkin genes: Insights of Parkinson’s disease. Molecular Biology Reports, 51(1), 586.

Chib, S., Dutta, B. J., Chalotra, R., Abubakar, M., Kumar, P., Singh, T. G., & Singh, R. (2025). Role of flavonoids in mitigating the pathological complexities and treatment hurdles in Alzheimer’s disease. Phytotherapy Research, 39(2), 747–775.

Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Published-on by Indian Scientist

Mr. Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Chitkara University Punjab | India

Ankush Kumar is a dedicated pharmaceutical researcher whose work spans medicinal chemistry, molecular modeling, and targeted drug design with a strong focus on anticancer therapeutics. He holds a solid academic foundation with qualifications in pharmaceutical chemistry and extensive research training that includes computational drug design, structure-activity exploration, and medicinal insights into heterocyclic scaffolds. His professional experience includes serving as a Junior Research Fellow and working as an Assistant Professor across multiple academic institutions, where he contributed to teaching, mentoring, and research development. His research outputs reflect a strong contribution to oncology-oriented drug discovery, with publications covering molecular targets, biomarkers, EGFR inhibition, heterocyclic synthesis, and computational repurposing studies. He has authored numerous research papers in reputed journals, contributing to a total of 561 citations, supported by an h-index of 6 and i10-index of 4, demonstrating the growing influence of his scientific contributions. His work includes book chapters and multiple peer-reviewed articles that highlight new therapeutic strategies and structural insights into various biological targets. He has received academic distinctions such as top positions in academic competitions and has served as a reviewer for international journals, further reflecting his scholarly engagement. Overall, his research trajectory reflects a commitment to advancing pharmaceutical innovation and precision-driven drug discovery.

Profile: Google Scholar

Featured Publications

Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z. S., Kumar, A., Vishakha, Jha, S. K., et al. (2023). Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Molecular Cancer, 22(1), 105.

Kumar, A., Sehgal, A., Singh, S., Sharma, N., Yadav, S., Rashid, S., Ali, N., et al. (2023). Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer. International Journal of Biological Macromolecules, Article 126595.

Zheng, M., Kumar, A., Sharma, V., Sehgal, A., Wal, P., Shinde, N. V., Kawaduji, B. S., et al. (2024). Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions. Frontiers in Cell and Developmental Biology, 12, Article 1353860.

Kumar, A., Kumar, B., & Bhatia, R. (2023). Design, synthesis, molecular docking, and biological evaluation of isatin-based fused heterocycles as epidermal growth factor receptor inhibitors. Assay and Drug Development Technologies, 21(5), 222–233.

Kumar, A., Narang, R. K., & Bhatia, R. (2023). Recent advancements in NS5B inhibitors (2011–2021): Structural insights, SAR studies and clinical status. Journal of Molecular Structure, 1293, Article 136272.